TARGETED THERAPIES IN RENAL CELL CARCINOMA

被引：0
|
作者：
Pook, David [1 ]
Davis, Ian D. [1 ]
机构：
[1] Inst Canc Res, Austin Hlth, Heidelberg, Vic, Australia
来源：
CANCER FORUM | 2008年 / 32卷 / 03期
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The landscape of treatment for renal cell carcinoma has changed radically over the last few years. Previously, the most effective treatments were too toxic, too expensive or too ineffective. Careful biological studies have uncovered pathways relevant to the survival, growth and spread of renal cell carcinoma and other cancers, and have highlighted rational targets for therapy. New agents aimed at these targets have been shown to be highly effective, but have brought with them a new range of toxicities and other complexities in the management of our patients. This review describes three drugs recently approved in Australia for use in advanced renal cell carcinoma and other agents of clinical and research interest.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Expression Patterns of Markers for Targeted Therapies in Renal Cell Carcinoma
    Sharma, S. G.
    Gokden, N.
    [J]. MODERN PATHOLOGY, 2010, 23 : 218A - 219A
  • [22] KIDNEY CANCER Neoadjuvant targeted therapies in renal cell carcinoma
    Ficarra, Vincenzo
    Novara, Giacomo
    [J]. NATURE REVIEWS UROLOGY, 2010, 7 (02) : 63 - 64
  • [23] KEEPING THE FAITH: TARGETED THERAPIES IN ADVANCED RENAL CELL CARCINOMA
    Pezaro, Carmel
    [J]. Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 98 - 98
  • [24] Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
    Conti, Alessandro
    Santoni, Matteo
    Amantini, Consuelo
    Burattini, Luciano
    Berardi, Rossana
    Santoni, Giorgio
    Cascinu, Stefano
    Muzzonigro, Giovanni
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [25] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    [J]. TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [26] Management of metastatic renal cell carcinoma in the era of targeted therapies
    Webber, K.
    Cooper, A.
    Kleiven, H.
    Yip, D.
    Goldstein, D.
    [J]. INTERNAL MEDICINE JOURNAL, 2011, 41 (08) : 594 - 605
  • [27] Targeted therapies for renal cell carcinoma: understanding their impact on survival
    Pal, Sumanta Kumar
    Figlin, Robert A.
    [J]. TARGETED ONCOLOGY, 2010, 5 (02) : 131 - 138
  • [28] Expression Patterns of Markers for Targeted Therapies in Renal Cell Carcinoma
    Sharma, S. G.
    Gokden, N.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 218A - 219A
  • [29] Targeted therapies in the management of renal cell carcinoma: role of bevacizuma
    Escudier, Bernard
    Cosaert, Jan
    Jethwa, Sangeeta
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 517 - 530
  • [30] Targeted therapies and the treatment of non-clear cell renal cell carcinoma
    Bellmunt, J.
    Dutcher, J.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (07) : 1730 - 1740
12345